Press release
Emphysema Treatment Global Market Analysis, Trends, Growth, Research And Forecast 2033
Emphysema Treatment Global Market
According to The Business Research Company's, The emphysema treatment market size has grown strongly in recent years. It will grow from $4.96 billion in 2023 to $5.29 billion in 2024 at a compound annual growth rate (CAGR) of 6.5%. The growth in the historic period can be attributed to smoking epidemic impact, advancements in medications, pulmonary rehabilitation programs, improved diagnostic tools, awareness and education..
The emphysema treatment market size is expected to see strong growth in the next few years. It will grow to $6.85 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to aging population trends, customized treatment approaches, expanded access to therapies, focus on symptom management, collaborative healthcare models.. Major trends in the forecast period include exploration of gene therapies, patient education and empowerment, integration of artificial intelligence (ai), increased accessibility to treatment, long-acting medications development..
Get The Complete Scope Of The Report @
https://www.thebusinessresearchcompany.com/report/emphysema-treatment-global-market-report
Market Drivers and Trends:
The rise in the prevalence of chronic obstructive pulmonary disease (COPD) cases is expected to propel the growth of the emphysema treatment market going forward. Chronic obstructive pulmonary disease (COPD) is a set of disorders that cause airflow obstruction and breathing difficulties, including emphysema and chronic bronchitis. Emphysema therapies are essential in reducing the advancement of Chronic Obstructive Pulmonary Disease (COPD) as they focus on treating symptoms, restoring lung function, and delaying disease progression. For instance, in September 2021, according to the study released by the Forum of International Respiratory Societies, a Switzerland-based respiratory health advocacy organization, an estimated 200 million people have COPD in 2021, with around 3.2 million dying each year, making it the third-leading cause of mortality globally. Therefore, the rise in the prevalence of chronic obstructive pulmonary disease (COPD) cases drives the emphysema treatment market.
Major companies operating in the emphysema market are developing minimally invasive procedures for emphysema patients to gain a competitive edge in the market. Minimally invasive procedures refer to medical interventions or surgical techniques that are performed with minimal disruption to the body's normal structures. For instance, in January 2022, Adena Health System, a US-based healthcare company, launched the Zephyr Valve surgery. It is a minimally invasive procedure that offers an alternative to conventional lung volume reduction surgery for individuals experiencing lung hyperinflation, a common issue in emphysema and COPD. This innovative approach involves placing small, one-way Zephyr Valves in the airways of the lungs via a bronchoscope. These valves facilitate the release of trapped air, preventing further accumulation, and allowing healthier lung areas to expand, thereby improving breathing.
Key Benefits for Stakeholders:
• Comprehensive Market Insights: Stakeholders gain access to detailed market statistics, trends, and analyses that help them understand the current and future landscape of their industry.
• Informed Decision-Making: The reports provide crucial data that support strategic decisions, reducing risks and enhancing business planning.
• Competitive Advantage: With in-depth competitor analysis and market share information, stakeholders can identify opportunities to outperform their competition.
• Tailored Solutions: The Business Research Company offers customized reports that address specific needs, ensuring stakeholders receive relevant and actionable insights.
• Global Perspective: The reports cover various regions and markets, providing a broad view that helps stakeholders expand and operate successfully on a global scale.
Ready to Dive into Something Exciting? Get Your Free Exclusive Sample of Our Research Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp
Major Key Players of the Market:
AstraZeneca PLC; Teva Pharmaceutical Industries Ltd.; Novartis AG; GlaxoSmithKline PLC; Hikma Pharmaceuticals PLC; Boehringer Ingelheim GmbH; Mylan N.V.; Pfizer Inc.; Orion Oyj; Verona Pharma PLC; Pulmonx Corporation; Bioxyne Limited; Intrexon Corporation; iCure Pharmaceuticals Inc.; Kamada Ltd.; Emphasys Medical Inc.; Halozyme Therapeutics Inc.; Mariposa Health Limited; Uptake Technologies Inc.; British Technology Group International ; Astellas Pharma Inc.; Respinova Ltd; Gala Therapeutics Inc.; Pulmatrix Inc.; Broncus Medical Inc.; Holaira Inc.; PneumRx Inc.; Spiration Inc.; Aeris Therapeutics Inc.; CSA Medical Inc.; Olympus Corporation
Emphysema Treatment Market 2024 Key Insights:
• The emphysema treatment market will grow to $6.85 billion in 2028 at a compound annual growth rate (CAGR) of 6.7%.
• Surging Cases Of Chronic Obstructive Pulmonary Disease (COPD) To Drive Market Growth
• Minimally Invasive Procedures Transforming The Market
• North America was the largest region in the emphysema treatment market in 2023
We Offer Customized Report, Click @
https://www.thebusinessresearchcompany.com/Customise?id=10807&type=smp
Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info
Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Emphysema Treatment Global Market Analysis, Trends, Growth, Research And Forecast 2033 here
News-ID: 3745908 • Views: …
More Releases from The Business research company
Seed Treatment Fungicides Market to Grow at 9.3% CAGR, Reaching $3.15 Billion by …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Seed Treatment Fungicides Market Outlook: How is the Market Expected to Grow by 2025?
Over the past few years, the market for seed treatment fungicides has seen robust growth. Its market value is projected to rise from $2.07 billion in 2024 to $2.21 billion in 2025, signifying a compound annual…
Rheology Modifiers Market Growth to be Driven by Emerging Trends | $10.92 Billio …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Rheology Modifiers Industry?
There has been a consistent expansion in the size of the rheology modifiers market in the past few years. The market, which was worth $8.59 billion in 2024, is projected to increase to $8.89 billion in 2025, demonstrating a compound…
Polyurethane Foam Market to Record 8.4% CAGR Growth Through 2029 | Global Analys …
Use ONLINE30 for 30% savings on global market reports and stay on top of tariff updates, market trends, and economic shifts worldwide.
Polyurethane Foam Market Outlook: How is the Market Expected to Grow by 2025?
In recent years, the size of the polyurethane foam market has experienced substantial growth. It is projected to increase from a value of $54.27 billion in 2024 to $57.26 billion in 2025, indicating a compound annual growth…
Pharmaceutical Intermediates Market Size to Reach $46.04 Billion by 2029 | Growt …
Stay informed on tariff shifts, macro trends, and global economic changes-use code ONLINE30 to enjoy 30% off our global market reports.
What is the Projected Market Size of the Pharmaceutical Intermediates Industry?
There has been consistent growth in the market size of pharmaceutical intermediates over the past few years. The market is predicted to increase from a value of $33.37 billion in 2024, up to $34.95 billion in 2025, with a compound…
More Releases for Emphysema
Emphysema Market: A Comprehensive Overview
Emphysema is a chronic lung disease that primarily affects the alveoli, or air sacs, in the lungs. It is one of the key components of chronic obstructive pulmonary disease (COPD), characterized by progressive difficulty in breathing due to damage to the air sacs, leading to reduced oxygen exchange. The global burden of emphysema is increasing, with more people being diagnosed as the aging population grows and environmental factors like smoking…
Emphysema Treatment Market Overview 2024-2033 - Share, Trends, Demand, Outlook
"The new report published by The Business Research Company, titled ""Emphysema Treatment Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033"", delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.
Download Free Sample Report @ https://www.thebusinessresearchcompany.com/sample.aspx?id=10807&type=smp
Surging Cases Of Chronic Obstructive Pulmonary Disease (COPD) To Drive Market Growth
The rise in the prevalence…
Emphysema Market: Global Industry Analysis and Forecast (2024-2030)
Emphysema Market to Hit USD 6.32 Bn at a growth rate of 4.28 percent- Says Stellar Market Research
The Emphysema Market size of the North America region is expected to dominate the market during the forecast period. The Emphysema Market is segmented into By Type, By Treatment, and By Distribution Channel for a better understanding of the market structure.
Stellar Market Research, a Healthcare business consultancy and research firm has published…
Navigating the Emphysema Treatment Market: Growth, Trends, and Size
Emphysema is a chronic obstructive pulmonary disease (COPD) characterized by the progressive destruction of the air sacs in the lungs, leading to reduced lung function and severe breathing difficulties. This condition is primarily caused by long-term exposure to irritants such as tobacco smoke, air pollution, and occupational dust and chemicals. As a result, the emphysema treatment market has emerged as a critical component of respiratory healthcare.
Emphysema patients experience symptoms like…
Emphysema Drug Market Will Generate Record Revenue by 2029
The Emphysema Drug Market size is expected to grow at an annual average of CAGR 4% during the forecast period (2023-2029). Emphysema is also referred as chronic obstructive disorder because inhalation and exhalation are slowed down due to over inflammation of alveoli. Emphysema can cause damage to air sac which results in change of shape of air sac or often destruction resulting in low gas exchanged in the lungs leading…
Worldwide Emphysema Market 2018 | Emphysema cases are High in Middle East, China …
Emphysema, a lung disease is characterized by the shortness of breath, thereby, damaging the air sacs in the lungs. The disease leads to rupture and weakening of inner walls of the air sacs over the period. The disease involves the reduction in the surface area of the lungs which in turn reduces the amount of oxygen reaching the bloodstream. Hence, during exhalation, the alveoli do not function properly leaving the…
